Keckley Report February 12, 2024
Paul Keckley

Last Monday, two lawsuits were filed that strike at a fundamental challenge facing the U.S. health system:

In the District Court of NJ, a class action lawsuit (ANN LEWANDOWSKI v THE PENSION & BENEFITS COMMITTEE OF JOHNSON AND JOHNSON) was filed against J&J alleging the company had mismanaged health benefits in violation of the Employee Retirement Income Security Act (“ERISA”). As noted in the 74-page filing “This case principally involves mismanagement of prescription-drug benefits. “Over the past several years, defendants breached their fiduciary duties and mismanaged Johnson and Johnson’s prescription-drug benefits program, costing their ERISA plans and their employees millions of dollars in the form of higher payments for prescription drugs, higher premiums, higher deductibles, higher coinsurance, higher copays, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Insurance, Provider, Self-insured
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health
Fatal work injuries in healthcare: 4 findings
Hospitals more likely to report suspected child abuse for Black children: Study
Best Buy Health Lays Out Biggest Lessons Learned From Hospital-At-Home
Kaiser Permanente buys surgery center building

Share This Article